0      0

AONN+ Annual 2021 Virtual Conference

FRI01 - Industry Sponsored Session | Urgent Treatment of Early-Onset Severe Toxicity of 5-FU or Capecitabine Presented by Wellstat Therapeutics

Nov 19, 2021 8:00am ‐ Nov 19, 2021 9:00am


Learning Objectives:

  • Describe the incidence and burden of early-onset severe toxicity in patients receiving 5-FU and capecitabine
  • Describe mechanism of action of 5-FU and its cytotoxic metabolites as it relates to the causes of early-onset severe toxicity
  • Recognize signs and symptoms of 5-FU and capecitabine early-onset severe toxicity
  • Summarize evidence supporting emergency treatment for patients with early-onset severe toxicity and following 5-FU or capecitabine overdoses
  • Review the importance of prompt treatment of overdoses and early-onset severe toxicity
  • Educate patients, caregivers, and colleagues about the importance of recognizing and urgently treating early-onset severe toxicity of 5-FU or capecitabine


  • Alice Beers, BSN, OCN, NPD-BC, Oncology Nurse Navigator, MedStar Georgetown Cancer Network at Washington Cancer Institute MedStar Washington Hospital Center

You must be logged in and own this session in order to post comments.